CN107083434B - Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus - Google Patents
Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus Download PDFInfo
- Publication number
- CN107083434B CN107083434B CN201710413728.0A CN201710413728A CN107083434B CN 107083434 B CN107083434 B CN 107083434B CN 201710413728 A CN201710413728 A CN 201710413728A CN 107083434 B CN107083434 B CN 107083434B
- Authority
- CN
- China
- Prior art keywords
- group
- streptococcus
- swab
- sample
- pcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000193990 Streptococcus sp. 'group B' Species 0.000 title claims abstract description 42
- 238000001514 detection method Methods 0.000 title claims abstract description 36
- 238000002203 pretreatment Methods 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 52
- 102000004317 Lyases Human genes 0.000 claims abstract description 21
- 108090000856 Lyases Proteins 0.000 claims abstract description 21
- 239000006166 lysate Substances 0.000 claims abstract description 16
- 238000012408 PCR amplification Methods 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 2
- 239000007995 HEPES buffer Substances 0.000 claims description 2
- 239000007987 MES buffer Substances 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 239000007986 glycine-NaOH buffer Substances 0.000 claims description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 15
- 241000194017 Streptococcus Species 0.000 abstract description 13
- 102000039446 nucleic acids Human genes 0.000 abstract description 13
- 108020004707 nucleic acids Proteins 0.000 abstract description 13
- 150000007523 nucleic acids Chemical class 0.000 abstract description 13
- 238000011065 in-situ storage Methods 0.000 abstract description 10
- 238000000605 extraction Methods 0.000 abstract description 6
- 239000000725 suspension Substances 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 238000005336 cracking Methods 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- 238000009835 boiling Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000010355 oscillation Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 31
- 230000003321 amplification Effects 0.000 description 15
- 238000003199 nucleic acid amplification method Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 8
- 230000009089 cytolysis Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000003753 real-time PCR Methods 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 125000006853 reporter group Chemical group 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 230000037006 agalactosis Effects 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 210000005000 reproductive tract Anatomy 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000193985 Streptococcus agalactiae Species 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000009984 peri-natal effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 229930194936 Tylosin Natural products 0.000 description 1
- 239000004182 Tylosin Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
- 229960004059 tylosin Drugs 0.000 description 1
- 235000019375 tylosin Nutrition 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000036266 weeks of gestation Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710413728.0A CN107083434B (en) | 2017-06-05 | 2017-06-05 | Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710413728.0A CN107083434B (en) | 2017-06-05 | 2017-06-05 | Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107083434A CN107083434A (en) | 2017-08-22 |
CN107083434B true CN107083434B (en) | 2020-09-08 |
Family
ID=59607892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710413728.0A Active CN107083434B (en) | 2017-06-05 | 2017-06-05 | Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107083434B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022213383A1 (en) * | 2021-04-09 | 2022-10-13 | 广州市达安医疗器械有限公司 | Closed nucleic acid test consumable and test method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297034A (en) * | 2005-08-24 | 2008-10-29 | 洛克菲勒大学 | PLY-GBS mutant lysins |
WO2011065854A1 (en) * | 2009-11-24 | 2011-06-03 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Enterococcal phage peptides and methods of use thereof |
CN103409509A (en) * | 2013-07-02 | 2013-11-27 | 江苏硕世生物科技有限公司 | Group B streptococcus fluorescence PCR detection kit |
CN105368946A (en) * | 2015-11-27 | 2016-03-02 | 湖南圣湘生物科技有限公司 | Group B streptococcus nucleic acid assay kit based on PCR (polymerase chain reaction) fluorescent probe method |
-
2017
- 2017-06-05 CN CN201710413728.0A patent/CN107083434B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297034A (en) * | 2005-08-24 | 2008-10-29 | 洛克菲勒大学 | PLY-GBS mutant lysins |
WO2011065854A1 (en) * | 2009-11-24 | 2011-06-03 | Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa | Enterococcal phage peptides and methods of use thereof |
CN103409509A (en) * | 2013-07-02 | 2013-11-27 | 江苏硕世生物科技有限公司 | Group B streptococcus fluorescence PCR detection kit |
CN105368946A (en) * | 2015-11-27 | 2016-03-02 | 湖南圣湘生物科技有限公司 | Group B streptococcus nucleic acid assay kit based on PCR (polymerase chain reaction) fluorescent probe method |
Non-Patent Citations (2)
Title |
---|
A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae;Roberto Díez-Martínez等;《Journal of Antimicrobial Chemotherapy》;20150301;第70卷(第6期);第1763-1773页 * |
孕妇B族链球菌感染荧光PCR检测技术的建立和应用;陈泳;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20160215(第2期);E068-81 * |
Also Published As
Publication number | Publication date |
---|---|
CN107083434A (en) | 2017-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103361429B (en) | LAMP detection primer, kit and detection method for staphylococcus aureus containing internal standard | |
CN106244725B (en) | Taqman real-time fluorescence PCR kit for diagnosing wild strain of porcine umbilical cord blood pseudorabies virus and application thereof | |
CN105420379A (en) | Real-time fluorescence quantification PCR detecting kit for cow mycoplasma and special primers and TaqMan probe thereof | |
Genné et al. | Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW) | |
WO2019075868A1 (en) | Method for detecting brucella infection and applications thereof | |
CN104450953B (en) | The avian influenza virus H7N9(2013 of RNA constant-temperature amplification) kit for detecting nucleic acid | |
CN104651535A (en) | Reverse transcription loop-mediated isothermal amplification test kit of hog cholera virus and application thereof | |
CN106967828A (en) | A kind of nucleic acid extracting reagent, kit and its method for being used to detect low-copy mycobacterium tuberculosis | |
CN107083434B (en) | Sample pretreatment method for non-diagnosis-purpose fluorescent PCR quantitative detection of group B streptococcus | |
CN104342496B (en) | A kind of quick detection, identify that Liszt belongs to the method for bacterium | |
CN110438260A (en) | A kind of African swine fever virus nucleic acid test strips detection kit | |
CN110184372A (en) | A kind of detection ox source Klebsiella Pneumoniae specific primer and its methods and applications | |
CN105349661A (en) | Chlamydia trachomatis and gonococcus nucleic acid detection kit | |
CN102134612B (en) | Rapid PCR (Polymerase Chain Reaction) testing method of silkworm densovirus BmDNV | |
CN103343170B (en) | RT-PCR (reverse transcription-polymerase chain reaction) detection kit for bovine viral diarrhea viruses | |
CN116555456B (en) | Detection method and application of mycobacterium tuberculosis Ag85B mRNA | |
CN109837331A (en) | Detect the primer pair and method of Vero cellular DNA fragments size distribution | |
CN101580883B (en) | Respiratory syncytial virus real-time fluorescence PCR detection kit | |
CN116334305A (en) | Primer probe combination for detecting African swine fever virus and application thereof | |
CN109055582A (en) | A kind of Mycoplasma bovis disease PCR quick diagnosis reagent kit | |
CN105567676B (en) | A kind of method for extracting nucleic acid and its dedicated kit | |
CN111088396A (en) | Triple real-time fluorescence PCR method for simultaneously detecting haemophilus parasuis, porcine parvovirus and porcine circovirus type 2 | |
CN113025733A (en) | Novel group B streptococcus nucleic acid PCR-colloidal gold immunochromatographic assay detection kit | |
CN113755614A (en) | Rapid high-sensitivity differential diagnosis kit for Brucella vaccine strain and wild strain and use method thereof | |
Nazeri | Evaluation of indirect immunofluorescence assay for diagnosis of Listeria monocytogenes in abortion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240703 Address after: No. 201, No. 24, Xiaohongshan West District, Wuchang District, Wuhan City, Hubei Province 430000 Patentee after: Yang Hang Country or region after: China Address before: 430000 Wuhan Donghu Development Zone High-tech Avenue 666 Wuhan National Biological Industry Base Project B, C, D Development Building B1 Patentee before: Wuhan Phagelux Bio-tech Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240807 Address after: Room 908, 9th Floor, Building A1, No. 30 Guanggu Nanda Health Industrial Park, Zhengdian Street, Jiangxia District, Wuhan City, Hubei Province, 430000 (Declaration of Commitment Registration) Patentee after: Hubei Zhimicrobiota Technology Co.,Ltd. Country or region after: China Address before: No. 201, No. 24, Xiaohongshan West District, Wuchang District, Wuhan City, Hubei Province 430000 Patentee before: Yang Hang Country or region before: China |
|
TR01 | Transfer of patent right |